ROIV:NASDAQ
Roivant Sciences Ltd
$35.78
arrow_upward
+0.17%(+0.060) 1D
$35.99
arrow_upward
+0.59% (+0.21)bedtimeAfter hours
Closed: Oct 5, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ROIV...
Open
$35.98
High
$36.32
Low
$35.24
Mkt. cap
25.84B
Avg. vol.
9.00M
Volume
6.20M
52-wk high
$42.50
52-wk low
$15.25
EPS
-$0.39
Beta
1.10
Shares outstanding
722.32M
No. of employees
721
Open
$35.98
High
$36.32
Low
$35.24
Mkt. cap
25.84B
Avg. vol.
9.00M
Volume
6.20M
52-wk high
$42.50
52-wk low
$15.25
EPS
-$0.39
Beta
1.10
Shares outstanding
722.32M
No. of employees
721
News stories
From web sources and news partners
Stock Titan
·
5 hours ago
Roivant Sciences (ROIV) director exercises $4.46 options and sells 17,750 shares.
Benzinga
·
16 hours ago
Transcript: Roivant Sciences Q1 2027 Earnings Conference Call
Oligarch Watch
·
1 month ago
How Vivek Ramaswamy’s mom manipulated Alzheimer’s data and made her son rich
Profile
Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel. Wikipedia
About Roivant Sciences Ltd